Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants.
Journal
Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
revised:
27
04
2023
received:
14
09
2022
accepted:
28
04
2023
medline:
4
12
2023
pubmed:
12
6
2023
entrez:
12
6
2023
Statut:
ppublish
Résumé
To assess case fatality rate (CFR), infant mortality, and long-term neurodevelopmental disorders (NDDs) after invasive group B streptococcal (GBS; Streptococcus agalactiae) infection in infants. Children born in Norway between 1996 and 2019 were included. Data on pregnancies/deliveries, GBS infection, NDDs, and causes of death were retrieved from five national registries. The exposure was culture-confirmed invasive GBS infection during infancy. Outcomes were mortality and NDDs, the latter at a mean age of 12 years 10 months. Among 1 415 625 live-born children, 866 (87%) of 1007 infants diagnosed with GBS infection (prevalence 0.71 per 1000) were included. The CFR was 5.0% (n = 43). GBS infection was associated with higher infant mortality (relative risk 19.41; 95% confidence interval [CI] 14.79-25.36) than the general population. Among survivors, 169 (20.7%) children were diagnosed with any NDD (relative risk 3.49; 95% CI 3.05-3.98). In particular, GBS meningitis was associated with high risks of attention-deficit/hyperactivity disorder, cerebral palsy, epilepsy, hearing impairment, and pervasive and specific developmental disorder. The burden of invasive GBS infection during infancy is considerable and continues to affect children beyond infancy. These findings emphasize the need for new preventive strategies for disease reduction, and the need for survivors to be directly included into early detection pathways to access early intervention if required. The burden of invasive group B streptococcal (GBS) infection in Norway is considerable. Of GBS infection survivors, 20.7% were diagnosed with neurodevelopmental disorders (NDDs) at mean age 12 years 10 months. Infants with GBS meningitis were more often diagnosed with NDDs. Absolute risks associated with GBS infections were highest for pervasive and specific developmental disorder, cerebral palsy, and attention-deficit/hyperactivity disorder.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-133Informations de copyright
© 2023 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
Références
Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160-S72.
Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics. 1997;99(3):489-96.
Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. JAMA Pediatr. 2019;173(3):224-33.
Kadambari S, Trotter CL, Heath PT, Goldacre MJ, Pollard AJ, Goldacre R. Group B Streptococcal Disease in England (1998 - 2017): A Population-based Observational Study. Clin Infect Dis. 2021;72(11):e791-e8.
Hayes K, O'Halloran F, Cotter L. A review of antibiotic resistance in Group B Streptococcus: the story so far. Crit Rev Microbiol. 2020;46(3):253-69.
Davies HG, Carreras-Abad C, Le Doare K, Heath PT. Group B Streptococcus: Trials and Tribulations. Pediatr Infect Dis J. 2019;38(6S Suppl 1):S72-S6.
Lawn JE, Chandna J, Paul P, Jit M, Trotter C, Lambach P, et al. Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide. Clin Infect Dis. 2022;74(Supplement_1):S1-S4.
Kohli-Lynch M, Russell NJ, Seale AC, Dangor Z, Tann CJ, Baker CJ, et al. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S190-S9.
Horváth-Puhó E, van Kassel MN, Gonçalves BP, de Gier B, Procter SR, Paul P, et al. Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study. Lancet Child Adolesc Health. 2021;5(6):398-407.
Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, et al. Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries. Clin Epidemiol. 2021;13:533-54.
Smith Jervelund S, De Montgomery CJ. Nordic registry data: value, validity and future. Scand J Public Health. 2020;48(1):1-4.
Lawn JE, Chandna J, Paul P, Jit M, Trotter C, Lambach P, et al. Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide. Clin Infect Dis. 2022;74(Suppl_1):S1-s4.
Bakken IJ, Ariansen AMS, Knudsen GP, Johansen KI, Vollset SE. The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries. Scand J Public Health. 2020;48(1):49-55.
Pedersen AG, Ellingsen CL. Data quality in the Causes of Death Registry. Tidsskr Nor Laegeforen. 2015;135(8):768-70.
Cantey JB, Baldridge C, Jamison R, Shanley LA. Late and very late onset group B Streptococcus sepsis: one and the same? World J Pediatr. 2014;10(1):24-8.
Fagerland MW, Lydersen S, Laake P. Recommended confidence intervals for two independent binomial proportions. Stat Methods Med Res. 2015;24(2):224-54.
Yeo KT, Lahra M, Bajuk B, Hilder L, Abdel-Latif ME, Wright IM, et al. Long-term outcomes after group B streptococcus infection: a cohort study. Arch Dis Child. 2019;104(2):172-8.
Mynarek M, Bjellmo S, Lydersen S, Afset JE, Andersen GL, Vik T. Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study. Pediatr Res. 2021;89(6):1541-8.
Dulac O, Lassonde M, Sarnat HB. Pediatric neurology. Edinburgh; New York: Elsevier; 2013. 3 volumes p.
Hollung SJ, Vik T, Wiik R, Bakken IJ, Andersen GL. Completeness and correctness of cerebral palsy diagnoses in two health registers: implications for estimating prevalence. Dev Med Child Neurol. 2017;59(4):402-6.
Aaberg KM, Gunnes N, Bakken IJ, Lund Soraas C, Berntsen A, Magnus P, et al. Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study. Pediatrics. 2017;139(5).
Ying Q, Wang S, Lou X, Ding J, Ding J. Burden and risk factors of invasive group B Streptococcus disease among neonates in a Chinese maternity hospital. BMC Infect Dis. 2019;19(1):123.
Karampatsas K, Davies H, Mynarek M, Andrews N, Heath PT, Le Doare K. Clinical Risk Factors Associated with Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-analyses. Clin Infect Dis. 2022 Sep 30;75(7):1255-1264.
Ananth CV, Schisterman EF. Confounding, causality, and confusion: the role of intermediate variables in interpreting observational studies in obstetrics. Am J Obstet Gynecol. 2017;217(2):167-75.
Horvath-Puho E, Snoek L, van Kassel MN, Goncalves BP, Chandna J, Procter SR, et al. Prematurity Modifies the Risk of Long-term Neurodevelopmental Impairments After Invasive Group B Streptococcus Infections During Infancy in Denmark and the Netherlands. Clin Infect Dis. 2022;74(Supplement_1):S44-S53.
Giannoni E, Berger C, Stocker M, Agyeman P, Posfay-Barbe KM, Heininger U, et al. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland. Pediatr Infect Dis J. 2016;35(2):222-4.
van Kassel MN, de Boer G, Teeri SAF, Jamrozy D, Bentley SD, Brouwer MC, van der Ende A, van de Beek D, Bijlsma MW. Molecular epidemiology and mortality of group B streptococcal meningitis and infant sepsis in the Netherlands: a 30-year nationwide surveillance study. Lancet Microbe. 2021;2(1):e32-e40.
John HB, Arumugam A, Priya M, Murugesan N, Rajendraprasad N, Rebekah G, et al. South Indian Children's Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study. Clin Infect Dis. 2022;74(Supplement_1):S24-S34.
Bramugy J, Mucasse H, Massora S, Vitorino P, Aerts C, Mandomando I, et al. Short- and Long-term Outcomes of Group B Streptococcus Invasive Disease in Mozambican Children: Results of a Matched Cohort and Retrospective Observational Study and Implications for Future Vaccine Introduction. Clin Infect Dis. 2022;74(Supplement_1):S14-S23.
Harden LM, Leahy S, Lala SG, Paul P, Chandna J, Lowick S, et al. South African Children: A Matched Cohort Study of Neurodevelopmental Impairment in Survivors of Invasive Group B Streptococcus Disease Aged 5 to 8 Years. Clin Infect Dis. 2022;74(Supplement_1):S5-S13.
Chandna J, Liu WH, Dangor Z, Leahy S, Sridhar S, John HB, et al. Emotional and Behavioral Outcomes in Childhood for Survivors of Invasive Group B Streptococcus Disease in Infancy: Findings From 5 Low- and Middle-Income Countries. Clin Infect Dis. 2022;74(Supplement_1):S35-S43.
Boychuck Z, Bussieres A, Goldschleger J, Majnemer A, Prompt G. Age at referral for diagnosis and rehabilitation services for cerebral palsy: a scoping review. Dev Med Child Neurol. 2019;61(8):908-14.
Ramakrishnan M, Ulland AJ, Steinhardt LC, Moisi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med. 2009;7:47.
Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12(5):389-94.
Johnson S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N. Autism spectrum disorders in extremely preterm children. J Pediatr. 2010;156(4):525-31 e2.
Indredavik MS, Vik T, Evensen KA, Skranes J, Taraldsen G, Brubakk AM. Perinatal risk and psychiatric outcome in adolescents born preterm with very low birth weight or term small for gestational age. J Dev Behav Pediatr. 2010;31(4):286-94.
Indredavik MS. Extremely preterm children at increased risk of autism spectrum disorders. Evid Based Ment Health. 2010;13(3):92.
Hafstrom M, Kallen K, Serenius F, Marsal K, Rehn E, Drake H, et al. Cerebral Palsy in Extremely Preterm Infants. Pediatrics. 2018;141(1).
Olsen JE, Lee KJ, Spittle AJ, Anderson PJ, Doyle LW, Cheong JLY, et al. The causal effect of being born extremely preterm or extremely low birthweight on neurodevelopment and social-emotional development at 2 years. Acta Paediatr. 2022;111(1):107-14.
Hee Chung E, Chou J, Brown KA. Neurodevelopmental outcomes of preterm infants: a recent literature review. Transl Pediatr. 2020;9(Suppl 1):S3-S8.